Hadrien Demagny

907 total citations · 1 hit paper
16 papers, 682 citations indexed

About

Hadrien Demagny is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Hadrien Demagny has authored 16 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Epidemiology and 5 papers in Oncology. Recurrent topics in Hadrien Demagny's work include Liver Disease Diagnosis and Treatment (7 papers), Drug Transport and Resistance Mechanisms (4 papers) and TGF-β signaling in diseases (4 papers). Hadrien Demagny is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Drug Transport and Resistance Mechanisms (4 papers) and TGF-β signaling in diseases (4 papers). Hadrien Demagny collaborates with scholars based in Switzerland, United States and Netherlands. Hadrien Demagny's co-authors include Kristina Schoonjans, Alessia Perino, Laura A. Velázquez‐Villegas, Edward M. De Robertis, Edward Eivers, Tatsuya Araki, Yu Sun, Pan Xu, Xu Wang and Maaike H. Oosterveer and has published in prestigious journals such as Cell, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Hadrien Demagny

15 papers receiving 678 citations

Hit Papers

Molecular physiology of bile acid signaling in health, di... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hadrien Demagny Switzerland 11 384 215 185 119 93 16 682
Meital Charni‐Natan Israel 10 347 0.9× 153 0.7× 131 0.7× 71 0.6× 57 0.6× 16 652
Cheng-Ming Chiang United States 8 381 1.0× 133 0.6× 145 0.8× 81 0.7× 131 1.4× 9 639
Céline Gheeraert France 15 536 1.4× 138 0.6× 290 1.6× 161 1.4× 130 1.4× 25 906
Raymond Reif Germany 15 265 0.7× 189 0.9× 155 0.8× 143 1.2× 59 0.6× 28 719
M. Cecilia Larocca Argentina 17 590 1.5× 227 1.1× 93 0.5× 180 1.5× 43 0.5× 36 883
Lingdi Wang China 16 366 1.0× 75 0.3× 171 0.9× 166 1.4× 92 1.0× 24 742
Jinzhi Wang China 17 395 1.0× 129 0.6× 80 0.4× 87 0.7× 46 0.5× 49 768
Kwang‐Hoon Song South Korea 9 311 0.8× 240 1.1× 171 0.9× 219 1.8× 45 0.5× 11 761
Zhaoxia Yang China 8 175 0.5× 79 0.4× 155 0.8× 75 0.6× 59 0.6× 19 474
Lian Shen China 16 229 0.6× 181 0.8× 97 0.5× 56 0.5× 61 0.7× 26 584

Countries citing papers authored by Hadrien Demagny

Since Specialization
Citations

This map shows the geographic impact of Hadrien Demagny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hadrien Demagny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hadrien Demagny more than expected).

Fields of papers citing papers by Hadrien Demagny

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hadrien Demagny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hadrien Demagny. The network helps show where Hadrien Demagny may publish in the future.

Co-authorship network of co-authors of Hadrien Demagny

This figure shows the co-authorship network connecting the top 25 collaborators of Hadrien Demagny. A scholar is included among the top collaborators of Hadrien Demagny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hadrien Demagny. Hadrien Demagny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ghasemi, Ali, Amaia Martínez-Usatorre, Yang Liu, et al.. (2025). Dendritic cell progenitors engineered to express extracellular-vesicle–internalizing receptors enhance cancer immunotherapy in mouse models. Nature Communications. 16(1). 9148–9148. 1 indexed citations
2.
Jalil, Antoine, Alessia Perino, Yuan Dong, et al.. (2025). Bile acid 7α-dehydroxylating bacteria accelerate injury-induced mucosal healing in the colon. EMBO Molecular Medicine. 17(5). 889–908. 5 indexed citations
3.
Demagny, Hadrien, Adrien Fauré, Giorgia Benegiamo, et al.. (2024). Wars1 downregulation in hepatocytes induces mitochondrial stress and disrupts metabolic homeostasis. Metabolism. 162. 156061–156061. 1 indexed citations
4.
Perino, Alessia, Hadrien Demagny, & Kristina Schoonjans. (2024). A microbial-derived succinylated bile acid to safeguard liver health. Cell. 187(11). 2687–2689. 4 indexed citations
5.
Demagny, Hadrien, Alessia Perino, & Kristina Schoonjans. (2024). Protecting liver health with microbial-derived succinylated bile acids. PubMed. 3(5). loae023–loae023.
6.
Sun, Yu, Hadrien Demagny, Adrien Fauré, et al.. (2023). Asparagine protects pericentral hepatocytes during acute liver injury. Journal of Clinical Investigation. 133(7). 22 indexed citations
7.
Demagny, Hadrien, Vera Lemos, Yu Sun, et al.. (2022). The Slc25a47 locus is a novel determinant of hepatic mitochondrial function implicated in liver fibrosis. Journal of Hepatology. 77(4). 1071–1082. 20 indexed citations
8.
Sun, Yu, Hadrien Demagny, & Kristina Schoonjans. (2021). Emerging functions of the nuclear receptor LRH-1 in liver physiology and pathology. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1867(8). 166145–166145. 29 indexed citations
9.
Perino, Alessia, Hadrien Demagny, Laura A. Velázquez‐Villegas, & Kristina Schoonjans. (2020). Molecular physiology of bile acid signaling in health, disease, and aging. Physiological Reviews. 101(2). 683–731. 296 indexed citations breakdown →
10.
Stein, Sokrates, Vera Lemos, Pan Xu, et al.. (2017). Impaired SUMOylation of nuclear receptor LRH-1 promotes nonalcoholic fatty liver disease. Journal of Clinical Investigation. 127(2). 583–592. 62 indexed citations
11.
Xu, Pan, Maaike H. Oosterveer, Sokrates Stein, et al.. (2016). LRH-1-dependent programming of mitochondrial glutamine processing drives liver cancer. Genes & Development. 30(11). 1255–1260. 57 indexed citations
12.
Demagny, Hadrien & Edward M. De Robertis. (2015). Smad4/DPC4: A barrier against tumor progression driven by RTK/Ras/Erk and Wnt/GSK3 signaling. Molecular & Cellular Oncology. 3(2). e989133–e989133. 13 indexed citations
13.
Demagny, Hadrien & Edward M. De Robertis. (2015). Point mutations in the tumor suppressor Smad4/DPC4 enhance its phosphorylation by GSK3 and reversibly inactivate TGF-β signaling. Molecular & Cellular Oncology. 3(1). e1025181–e1025181. 28 indexed citations
14.
Demagny, Hadrien, Tatsuya Araki, & Edward M. De Robertis. (2014). The Tumor Suppressor Smad4/DPC4 Is Regulated by Phosphorylations that Integrate FGF, Wnt, and TGF-β Signaling. Cell Reports. 9(2). 688–700. 66 indexed citations
15.
Eivers, Edward, et al.. (2011). Phosphorylation of Mad Controls Competition Between Wingless and BMP Signaling. Science Signaling. 4(194). ra68–ra68. 26 indexed citations
16.
Eivers, Edward, Hadrien Demagny, & Edward M. De Robertis. (2009). Integration of BMP and Wnt signaling via vertebrate Smad1/5/8 and Drosophila Mad. Cytokine & Growth Factor Reviews. 20(5-6). 357–365. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026